We have many clinical trials open that involve radiation therapy for cancer open for enrollment of patients. The trials for specific types of cancer are listed below.
About Clinical Trials
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are done to find out if new cancer treatments are effective, safe and better than the standard treatment. Many of today’s standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment. Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and improve the treatment of cancer.
Biocept CNSide (FORESEE): A Longitudinal Therapy Response Monitoring Study with Leptomeningeal Metastases Using CNSide (CSF Tumor Cells) Compared to Standard of Care (CSF Cytology, Clinical Evaluation, and Imaging)
Read More at ClinicalTrials.govInvestigators: Jonathan Yang, MD, PhD
DebioPharm: A Phase 1/2 open-label study of Debio 0123 in combination with temozolomide in adult participants with recurrent or progressive glioblastoma and of Debio 0123 in combination with temozolomide and radiotherapy in adult participants with newly diagnosed glioblastoma
Read More at ClinicalTrials.govInvestigators: Jonathan Yang, MD, PhD
Biorepository for Biomarker Development for Brain Tumors
Read More at ClinicalTrials.govInvestigators: Jonathan Yang, MD, PhD
A Phase II Randomized Trial of Proton vs. Photon Therapy – NRG-BN005
Read More at ClinicalTrials.govInvestigators: Yolanda Tseng, MD
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer
Read More at ClinicalTrials.govInvestigators: Janice Kim, MD
RADCOMP: pragmatic randomized trial of proton vs. photon therapy for patients with stage II or III breast cancer / RADCOMP ANCILLARY
Read More at ClinicalTrials.govInvestigators: Waylene Wang, MD
A Phase III Randomized Trial of Protons versus Photons for Hepatocellular Carcinoma
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
GRECO-2: A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic Cancer
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
Functional liver imaging with sulfur colloid SPECT/CT in primary and metastatic liver cancer patients receiving liver-directed treatment: a pilot study
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801). A randomised phase 3 double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high risk, clinically localised prostate cancer.
Read More at ClinicalTrials.govPhase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer.
Read More at ClinicalTrials.govPhase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Read More at ClinicalTrials.govPhase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients with Post-ProstaTEctomy Biochemical Recurrence (INDICATE)
Read More at ClinicalTrials.govInvestigators: Jonathan Chen, MD, PhD
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer: A Prospective Registry Trial
Read More at ClinicalTrials.govInvestigators: Jay Liao, MD
RAMPART: A Phase II, Multicenter, Single-Arm Clinical Trial of Definitive Radiotherapy and CeMiPlimAb-Rwlc ImmunoTherapy for Locally Advanced, Unresectable Cutaneous Squamous Cell Carcinoma
Read More at ClinicalTrials.govInvestigators: Upendra Parvathaneni, MB, FRANCR
Randomized Phase II/III Trial of Radiation With High-Dose Cisplatin (100Mg/M2 ) Every Three Weeks Versus Radiation With Low-Dose Weekly Cisplatin (30Mg/M2) For Patients With Locoregionally Advanced Squamous Cell Carcinoma Of the Head and Neck (SCCHN)
Read More at ClinicalTrials.govRandomized Phase II/III Trial Of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, Or Cisplatin-Atezolizumab In Pathologic High-Risk Squamous Cell Cancer Of The Head And Neck
Read More at ClinicalTrials.govA Double Blind, Placebo Controlled Dose Range Finding Study to Assess the Safety, Pharmacokinetics, and Efficacy of TEMPOL for the Reduction of Severe Mucositis in Head and Neck Cancer Patients Undergoing Combined Radio- and Chemotherapy
Read More at ClinicalTrials.govInvestigators: Jay Liao, MD
CASPIAN-RT Trial: Hypofractionated consolidative radiation therapy after Durvalumab (MEDI4736) plus platinum-based chemotherapy in extensive stage small cell lung cancer
Read More at ClinicalTrials.govInvestigators: Jing Zeng, MD
A Phase III, Randomized, Placebo-controlled, Double blind, Multi-center, International Study of Durvalumab Following SBRT for the Treatment of Patients with unresected Stage I/II, lymph-node negative Non-small Cell Lung Cancer (PACIFIC4/RTOG-3515)
Read More at ClinicalTrials.govInvestigators: Jing Zeng, MD
A Phase I Study Assessing the Safety and Tolerability of Ascending Doses of AZD1390 in Combination with Stereotactic Body Radiation Therapy (SBRT) in Patients with Metastatic Solid Tumor Malignancies
Read More at ClinicalTrials.govInvestigators: Jonathan Yang, MD, PhD
Kazia: A Phase I Study with Expansion Cohort of Concurrent GDC-0084 with Radiation Therapy for Patients with Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations
Read More at ClinicalTrials.govInvestigators: Jonathan Yang, MD, PhD
Increasing Native Radiation Oncology Access: Disparities and Solutions (INROADS) – Provider Survey / INROADS – Patient Survey
Read More at ClinicalTrials.govInvestigators: Lia Halasz, MD
Radiation Oncology Peripheral Blood Banking Protocol to Examine Immunologic Changes After Radiation Therapy
Read More at ClinicalTrials.govInvestigators: Jing Zeng, MD
Biodosimetry: Quantitation of radiation induced protein adducts using mass spectrometry
Read More at ClinicalTrials.govInvestigators: Peter Goff, MD, PhD
Pediatric proton consortium registry (PPCR): A MultiCenter Registry of Pediatric Patients Treated with Proton Radiation Therapy
Read More at ClinicalTrials.govInvestigators: Ralph Ermoian, MD
Evaluation Tracking Project: A Prospective Chart Review of Patients Treated with Radiation Therapy
Read More at ClinicalTrials.govInvestigators: Jing Zeng, MD